As Sp1 and Sp3 are overexpressed in most cancer types [47], have been characterized as non-oncogene addiction genes [48], and have been studied as potential biomarkers for recurrent PCa [49], these key findings highlight the importance of examining the AR, Sp1 and Sp3 signaling axis in PCa. The gene discussed is SP1; the disease is cancer.